Tapewire

Nasdaq · USD

AVXL

ANAVEX LIFE SCIENCES CORP.

Export transactions ↓
Tapewire entity
6086
SEC CIK
0001314052
Parsed reports
126

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 05, 2017 Filed Sep 5, 2017 14:20 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $4.90 $1,837.50
Disclosure

SEC source: 0001615774-17-004918 · s107406_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,006,625

F1 · kind: The purchase reported in this form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 31, 2017 Filed Aug 31, 2017 14:45 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $4.48 $1,680.00
Disclosure

SEC source: 0001615774-17-004886 · s107395_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,006,250

F1 · kind: The purchase reported in this form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 28, 2017 Filed Aug 29, 2017 11:12 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $4.44 $1,665.00
Disclosure

SEC source: 0001615774-17-004809 · s107368_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,005,875

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 24, 2017 Filed Aug 25, 2017 14:18 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $4.54 $1,702.50
Disclosure

SEC source: 0001615774-17-004745 · s107350_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,005,500

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 21, 2017 Filed Aug 21, 2017 11:42 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $4.07 $1,526.25
Disclosure

SEC source: 0001615774-17-004587 · s107276_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,005,125

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 18, 2017 Filed Aug 18, 2017 16:54 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $3.81 $1,428.75
Disclosure

SEC source: 0001615774-17-004574 · s107265_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,004,750

F1 · kind: The purchase reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 14, 2017 Filed Aug 14, 2017 17:12 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 375 $3.70 $1,387.50
Disclosure

SEC source: 0001615774-17-004399 · s107188_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,004,375

F1 · kind: The purchase reported in this form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
August 11, 2017 Filed Aug 11, 2017 16:35 UTC
MISSLING CHRISTOPHER UDirector · President and CEO
PurchaseCommon Stock 750 $3.55 $2,662.50
Disclosure

SEC source: 0001615774-17-004281 · s107162_form4.xml · nonDerivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,004,000

F1 · kind: The purchase reported in this form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 9, 2017.

Read SEC document
May 12, 2017 Filed May 15, 2017 17:15 UTC
MISSLING CHRISTOPHER UDirector · President & CEO
GrantStock Option (Right to Buy) · Derivative 450,000 $0.00 Strike: $5.92 $0.00
Disclosure

SEC source: 0001615774-17-002453 · s106224_form4.xml · derivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common Stock · 450,000 shares

Expires 2027-05-12

F1 · derivative.exercise_date: The options shall vest quarterly over a three-year period commencing on June 30, 2017.

Read SEC document
May 12, 2017 Filed May 15, 2017 21:14 UTC
Boenisch SandraPFO & Treasurer
GrantStock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $5.92 $0.00
Disclosure

SEC source: 0001615774-17-002450 · s106223_form4.xml · derivative · entry 1

Boenisch Sandra · CIK 0001655366 · PFO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2027-05-12

F1 · derivative.exercise_date: The options shall vest quarterly over a three-year period commencing on June 30, 2017.

Read SEC document
September 22, 2016 Filed Sep 26, 2016 17:12 UTC
MISSLING CHRISTOPHER UDirector · President, CEO & Treasurer
GrantStock Option (Right to Buy) · Derivative 500,000 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007378 · s104214_form4.xml · derivative · entry 1

MISSLING CHRISTOPHER U · CIK 0001196573 · Director · President, CEO & Treasurer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2026-09-22

Read SEC document
September 22, 2016 Filed Sep 26, 2016 21:24 UTC
FAVUS ELLIOTDirector
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007390 · s104219_form4.xml · derivative · entry 1

FAVUS ELLIOT · CIK 0001608022 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-22

Read SEC document
September 22, 2016 Filed Sep 26, 2016 21:23 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007388 · s104218_form4.xml · derivative · entry 1

Skarpelos Athanasios · CIK 0001360570 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-22

Read SEC document
September 22, 2016 Filed Sep 26, 2016 21:21 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007386 · s104217_form4.xml · derivative · entry 1

METZNER BERND · CIK 0001608592 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-22

Read SEC document
September 22, 2016 Filed Sep 26, 2016 21:18 UTC GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007384 · s104216_form4.xml · derivative · entry 1

Thomas Steffen · CIK 0001646396 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2026-09-22

Read SEC document
September 22, 2016 Filed Sep 26, 2016 21:14 UTC
Boenisch SandraPrincipal Financial Officer
GrantStock Option (Right to Buy) · Derivative 106,696 $0.00 Strike: $3.28 $0.00
Disclosure

SEC source: 0001615774-16-007380 · s104215_form4.xml · derivative · entry 1

Boenisch Sandra · CIK 0001655366 · Principal Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,696

Underlying: Common Stock · 106,696 shares

Expires 2026-09-22

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.